معرفی
Sarah Laing is a Research Associate at the CRUK Scotland Institute and a Widening Participation Postgraduate Tutor in External Relations at the University of Glasgow. Her work bridges cancer biology and translational research, focusing on molecular mechanisms in tumorigenesis and RNA integrity.
- Role 1: Research Associate, CRUK Scotland Institute
- Role 2: Widening Participation Postgraduate Tutor, External Relations
Research Interests: Laing’s research explores RNA integrity in translational control methods, KRAS-driven tumorigenesis in lung cancer, and immune evasion in pancreatic ductal adenocarcinoma. She investigates how oncogenes like MYC and KRAS interact with signaling pathways (e.g., ERBB network, type I interferon) to influence tumor progression and immune responses.
Recent Publications: Her articles (2018–2023) focus on cancer biology, immunology, and molecular diagnostics. Key subfields include pancreatic cancer, lung cancer, RNA preservation, KRAS mutations, ERBB signaling, and interferon pathway suppression.
Grants: She holds a grant from the Beatson Cancer Charity (2025–2027) for pharmacological inhibition of MYC in lung cancer research.
